Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo A Pinna

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Biomed Research International|November 12, 2015
Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDBCristina Girardi, Daniele Ottaviani, Lorenzo A Pinna, et al.
Journal of Proteome Research|May 11, 2010
Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteomeMauro Salvi, Luca Cesaro, Elena Tibaldi, et al.
The Biochemical Journal|February 27, 2013
Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activationAndrea Venerando, Cristina Girardi, Maria Ruzzene, et al.
Trends in Biochemical Sciences|January 2, 2013
Secreted protein kinasesVincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Trends in Biochemical Sciences|September 3, 2013
Response to Wang et al.: Secreted protein kinases?Vincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Biomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.
Oncogene|May 31, 2002
CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradationFrancesca Semplici, Flavio Meggio, Lorenzo A Pinna, et al.
Cell Death Discovery|October 30, 2021
Targeting CK2 in cancer: a valuable strategy or a waste of time?Mauro Salvi, Christian Borgo, Lorenzo A Pinna, et al.
Biochimica Et Biophysica Acta|April 18, 2015
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarinCinzia Franchin, Mauro Salvi, Giorgio Arrigoni, et al.
Methods in Enzymology|November 2, 2010
Assessment of CK2 constitutive activity in cancer cellsMaria Ruzzene, Giovanni Di Maira, Kendra Tosoni, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Biomed Research International|November 12, 2015
Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDBCristina Girardi, Daniele Ottaviani, Lorenzo A Pinna, et al.
Journal of Proteome Research|May 11, 2010
Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteomeMauro Salvi, Luca Cesaro, Elena Tibaldi, et al.
The Biochemical Journal|February 27, 2013
Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activationAndrea Venerando, Cristina Girardi, Maria Ruzzene, et al.
Trends in Biochemical Sciences|January 2, 2013
Secreted protein kinasesVincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Trends in Biochemical Sciences|September 3, 2013
Response to Wang et al.: Secreted protein kinases?Vincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Biomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.
Oncogene|May 31, 2002
CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradationFrancesca Semplici, Flavio Meggio, Lorenzo A Pinna, et al.
Cell Death Discovery|October 30, 2021
Targeting CK2 in cancer: a valuable strategy or a waste of time?Mauro Salvi, Christian Borgo, Lorenzo A Pinna, et al.
Biochimica Et Biophysica Acta|April 18, 2015
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarinCinzia Franchin, Mauro Salvi, Giorgio Arrigoni, et al.
Methods in Enzymology|November 2, 2010
Assessment of CK2 constitutive activity in cancer cellsMaria Ruzzene, Giovanni Di Maira, Kendra Tosoni, et al.
Pageof 17